MODULATORS OF SORTILIN ACTIVITY

The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical compositions comprising the compounds of the invention, and to their use...

Full description

Saved in:
Bibliographic Details
Main Authors KJØLBY, Mads Fuglsang, NYKJÆR, Anders, LITTLE, Paul Brian, CASES-THOMAS, Manuel Javier
Format Patent
LanguageEnglish
French
Published 12.09.2024
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical compositions comprising the compounds of the invention, and to their use in the treatment or prevention of medical conditions in which modulation of sortilin is beneficial. La présente invention concerne des composés de formule (I) ou un sel, solvate, hydrate, tautomère, isomère optique, N oxyde et/ou promédicament pharmaceutiquement acceptable de ceux-ci. La présente invention concerne également des compositions pharmaceutiques comprenant les composés de l'invention, et leur utilisation dans le traitement ou la prévention d'états pathologiques dans lesquels la modulation de la sortiline a des effets bénéfiques.
Bibliography:Application Number: WO2024EP56040